Creative Planning Adma Biologics, Inc. Transaction History
Creative Planning
- $93.6 Billion
- Q2 2024
A detailed history of Creative Planning transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Creative Planning holds 36,147 shares of ADMA stock, worth $722,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,147
Previous 20,784
73.92%
Holding current value
$722,578
Previous $137,000
194.89%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$373 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$290 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$263 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$178 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$161 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.93B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...